Search by Drug Name or NDC

    NDC 16714-0578-01 Azacitidine 100 mg/1 Details

    Azacitidine 100 mg/1

    Azacitidine is a INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar RxLLC. The primary component is AZACITIDINE.

    Product Information

    NDC 16714-0578
    Product ID 16714-578_ee4ad9f3-8ded-53f0-e053-2995a90ae065
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Azacitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Azacitidine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name AZACITIDINE
    Labeler Name NorthStar RxLLC
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207475
    Listing Certified Through 2024-12-31

    Package

    NDC 16714-0578-01 (16714057801)

    NDC Package Code 16714-578-01
    Billing NDC 16714057801
    Package 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16714-578-01)
    Marketing Start Date 2022-11-18
    NDC Exclude Flag N
    Pricing Information N/A
    << 16714-0577-02 16714-0590-01 >>

    Contents